Zobrazeno 1 - 10
of 148
pro vyhledávání: '"Ronit, Yerushalmi"'
Autor:
Ohad Benjamini, Shalev Fried, Roni Shouval, Jessica R. Flynn, Ofrat Beyar-Katz, Lori A Leslie, Tsilla Zucherman, Ronit Yerushalmi, Noga Shem-Tov, Maria Lia Palomba, Ivetta Danylesko, Inbal Sdayoor, Hila Malka, Orit Itzhaki, Hyung Suh, Sean M. Devlin, Ronit Marcus, Parastoo B Dahi, Elad Jacoby, Gunjan L Shah, Craig S Sauter, Andrew Ip, Miguel-Angel Perales, Arnon Nagler, Avichai Shimoni, Michael Scordo, Abraham Avigdor
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
The activity of anti-CD19 CAR T cell therapy in chronic lymphocytic leukemia (CLL) with Richter's transformation (RT) to aggressive large B cell lymphoma (LBCL) is largely unknown. In a multicenter retrospective study, we report the safety and effica
Externí odkaz:
https://doaj.org/article/446c107a98b1415f962e7e3be018edfa
Autor:
Ivetta Danylesko, Noga Shem-Tov, Ronit Yerushalmi, Elad Jacoby, Amos Toren, Orit Itzhaki, Roni Shouval, Avichai Shimoni, Avigdor Abraham, Arnon Nagler
Publikováno v:
HemaSphere, Vol 7, p e4369964 (2023)
Externí odkaz:
https://doaj.org/article/e68ac14296cc471fad149493a36eb6c7
Autor:
Hila Magen, Shalev Fried, Orit Itzhaki, Noga Shem-Tov, Ivetta Danylesko, Ronit Yerushalmi, Roni Shouval, Ronit Marcus, Lee Nevo, Ronnie Shapira-Frommer, Arnon Nagler, Avichai Shimoni, Eden Shkury, Avigdor Abraham
Publikováno v:
HemaSphere, Vol 7, p e94543ab (2023)
Externí odkaz:
https://doaj.org/article/1d67fdbc161e4daf84b517bbc9b5b53a
Autor:
Mika Geva, Shalev Fried, Orit Itzhaki, Noga Shem-Tov, Ivetta Danylesko, Ronit Yerushalmi, Ronit Marcus, Inbal Sdayoor, Ronnie Shapira-Frommer, Meirav Kedmi, Roni Shouval, Arnon Nagler, Avichai Shimoni, Abraham Avigdor
Publikováno v:
HemaSphere, Vol 7, p e62933fb (2023)
Externí odkaz:
https://doaj.org/article/e0575545a9cb4703885b16f12c06ef66
Autor:
Yaara Yerushalmi, Noga Shem-Tov, Ivetta Danylesko, Jonathan Canaani, Abraham Avigdor, Ronit Yerushalmi, Arnon Nagler, Avichai Shimoni
Publikováno v:
Haematologica, Vol 108, Iss 7 (2022)
Second allogeneic hematopoietic stem-cell transplantation (HSCT2) is a therapeutic option for patients with acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS) relapsing after a first transplant (HSCT1). However, patients allocated to HSCT2 m
Externí odkaz:
https://doaj.org/article/2c026f95013347f9a2f10827bb605435
Autor:
Ana Alarcon Tomas, Joshua A. Fein, Shalev Fried, Jessica R. Flynn, Sean M. Devlin, Warren B. Fingrut, Theodora Anagnostou, Anna Alperovich, Nishi Shah, Ellen Fraint, Richard J. Lin, Michael Scordo, Connie Lee Batlevi, Michal J. Besser, Parastoo B. Dahi, Ivetta Danylesko, Sergio Giralt, Brandon S. Imber, Elad Jacoby, Meirav Kedmi, Arnon Nagler, M. Lia Palomba, Mikhail Roshal, Gilles A. Salles, Craig Sauter, Noga Shem-Tov, Avichai Shimoni, Joachim Yahalom, Ronit Yerushalmi, Gunjan L. Shah, Abraham Avigdor, Miguel-Angel Perales, Roni Shouval
Publikováno v:
Leukemia
Persistence or recurrence of large B-cell lymphoma after CD19-CAR-T is common, yet data guiding management are limited. We describe outcomes and features following CAR-T treatment failure. Of 305 adults who received CD19-CAR-T, 182 experienced diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d5c3e97fb33a93f03dae0b199594bd8
https://doi.org/10.1038/s41375-022-01739-2
https://doi.org/10.1038/s41375-022-01739-2
Autor:
Ming Ni, Lei Wang, Mingya Yang, Brigitte Neuber, Leopold Sellner, Angela Hückelhoven-Krauss, Maria-Luisa Schubert, Thomas Luft, Ute Hegenbart, Stefan Schönland, Patrick Wuchter, Bao-an Chen, Volker Eckstein, William Krüger, Ronit Yerushalmi, Katia Beider, Arnon Nagler, Carsten Müller-Tidow, Peter Dreger, Michael Schmitt, Anita Schmitt
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
CD56bri natural killer (NK) cells play an important role in the pathogenesis of graft-vs. -host disease (GVHD) and immune defense in the early period after allogeneic hematopoietic stem cell transplantation. Extracorporeal photopheresis (ECP) as an i
Externí odkaz:
https://doaj.org/article/3d6c75863e2c4034873565fb0cd070dc
Autor:
Jacob Schachter, Arnon Nagler, Avichai Shimoni, Eytan Ben-Ami, Alon Ben-Nun, Sara Apter, Ronit Yerushalmi, Gal Markel, Bruria Shalmon, Daniel Ohayon, Yaara Ohayon, Dragoslav Zikich, Noa Shoshani, Adva Kubi, Daphna Levy, Douglas B. Zippel, Avraham J. Treves, Orit Itzhaki, Ronnie Shapira-Frommer, Michal J. Besser
PDF file - 60K, the baseline characteristics and response to ipilimumab in 19 patients previously treated with TIL ACT.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::619e5e4c5f7c46dc2fec1a71e0fcd835
https://doi.org/10.1158/1078-0432.22446417.v1
https://doi.org/10.1158/1078-0432.22446417.v1
Autor:
Jacob Schachter, Arnon Nagler, Avichai Shimoni, Eytan Ben-Ami, Alon Ben-Nun, Sara Apter, Ronit Yerushalmi, Gal Markel, Bruria Shalmon, Daniel Ohayon, Yaara Ohayon, Dragoslav Zikich, Noa Shoshani, Adva Kubi, Daphna Levy, Douglas B. Zippel, Avraham J. Treves, Orit Itzhaki, Ronnie Shapira-Frommer, Michal J. Besser
PDF file - 74K, the baseline and treatment characteristics of evaluated TIL patients treated with or without ipilimumab before TIL ACT.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50c20ef41de48768bfe42396034a20cf
https://doi.org/10.1158/1078-0432.22446420
https://doi.org/10.1158/1078-0432.22446420
Autor:
Jacob Schachter, Arnon Nagler, Avichai Shimoni, Eytan Ben-Ami, Alon Ben-Nun, Sara Apter, Ronit Yerushalmi, Gal Markel, Bruria Shalmon, Daniel Ohayon, Yaara Ohayon, Dragoslav Zikich, Noa Shoshani, Adva Kubi, Daphna Levy, Douglas B. Zippel, Avraham J. Treves, Orit Itzhaki, Ronnie Shapira-Frommer, Michal J. Besser
CCR Translation for This Article from Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86d7e3214005d73a92538fe2f755c1de
https://doi.org/10.1158/1078-0432.22446429.v1
https://doi.org/10.1158/1078-0432.22446429.v1